Sanofi logo SNYNF - Sanofi

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 11
HOLD 9
SELL 3
STRONG
SELL 0
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Undervalued Moderate
Trading 32.3% below fair value
Current Price $88.50
Bear Case $112.01 26.6% upside ($112.01 - $88.50) / $88.50 = 26.6% $9.33 × 12x P/E
Fair Value $130.67 47.7% upside ($130.67 - $88.50) / $88.50 = 47.7% $9.33 × 14x P/E
Bull Case $149.34 68.7% upside ($149.34 - $88.50) / $88.50 = 68.7% $9.33 × 16x P/E

Adjust Assumptions

14.0x
9.33$

Key Value Driver

Normalized P/E multiple (14x base case)

Implied Market Multiple 9.5x

Plain-Language Summary

Applying a 14x P/E to adjusted EPS of $9.33, the base-case value is $130.67 per share.

Warnings

⚠ The company pays out 249% of its profits as dividends. That leaves little cushion — the dividend could be cut if business slows down.
ℹ Financial statements were converted from EUR into USD using EURUSD at 1.1375 USD per EUR.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples